“cancer” Archives

in
Entry Author Date Location
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D 09/05/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug 08/13/19 Boston
AIQ Solutions Hits On $3.2M to Pinpoint Drug-Resistant Tumors 08/07/19 Wisconsin
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown 07/25/19 National
Bristol, With Another Lung Cancer Flop, Loses More Ground to Merck 07/24/19 New York
Freenome Snags $160M to Boost Blood Test for Early Cancer Detection 07/24/19 San Francisco
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Kronos Bio Reels In $105M for Drugs That Hit “Undruggable” Targets 07/18/19 San Francisco
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
After Amgen’s Spark, Revolution Med Nabs $100M to Push RAS Cancer Drugs 07/09/19 San Francisco
BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut 06/27/19 San Francisco
Mirati Stock Sale Targets $200M as Lead Cancer Drug Starts Phase 3 06/26/19 San Diego
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Page 1 of 79 next page »